進行乳癌における末梢性骨髄由来抑制細胞の予後的意義
Haruka Kanaoka1, Masayuki Nagahashi2, Junko Tsuchida1
1Division of Breast and Endocrine Surgery, Department of Surgery, School of Medicine, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya, 663-8501, Hyogo, Japan.
Breast cancer (Tokyo, Japan)
|February 23, 2026
まとめ
No abstract available in PubMed .


